Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| VAG0156-2 | 7 days | 2 µg | $120.00 |
Select product before adding to cart
|
||
| VAG0156-10 | 7 days | 10 µg | $400.00 | |||
| VAG0156-100 | 7 days | 100 µg | $2,880.00 |
Product Overview | |
| Name | H1N1 Puerto Rico Recombinant |
|---|---|
| Description | |
| H1N1 Influenza A- Virus Puerto Rico 08/1934 Recombinant | |
| Introduction | |
| H1N1 is a subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flu strain, mild human flu strains, endemic pigstrains, and various strains found in birds. The Influenza A Virus is a globular particle about 100nm in diameter, sheathed in a lipid bilayer derived from the plasma membrane of its host. Studded in the lipid bilayer are two integral membrane proteins some 500 molecules of hemagglutinin ("H") and some 100 molecules of neuraminidase ("N"). Within the lipid bilayer are 3000 molecules of matrix protein and 8 pieces of RNA. Each of the 8 RNA molecules is associated with many copies of a nucleoprotein, several molecules of the three subunits of its RNA polymerase some "non-structural" protein molecules of uncertain function. | |
| Source | |
| Baculovirus Insect Cells. | |
| Physical Appearance | |
| Sterile Filtered colorless solution. | |
| Formulation | |
| The Recombinant H1N1 A/Solomon Islands/03/2006 solution contains 10mM Sodium phosphate, pH 7.1,150mM NaCl and 0.005% Tween-20. | |
| Stability | |
| H1N1 A/Solomon Islands/03/2006 Recombinant should be stored at 4°C. | |
| Purity | |
| Greater than 90.0% as determined by SDS-PAGE. | |
| References | |
| 1. Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection Publication : The Rockefeller University Press , doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link : H1N1 Solomon Islands prospec publication 2. Title :Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. Publication :The Journal of Clinical Investigation http://www.jci.org Volume 120 Number 5 May 2010. Link : H1N1 Solomon Islands Virus prospec publication | |
| Immunological Activity | |
| Western-Blot 0.1 µg -1 µg per strip, ELISA 1 µg/Well. | |
| Precautions | |
| H1N1 Puerto Rico Recombinant is for research use only and not for use in diagnostic or therapeutic procedures. | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
